In Person Seminar: U.S. Tobacco Companies Flooded the U.S. Food Supply with Hyper-palatable Foods: Implications for Our Food Environment and Public Health
Tera Fazzino, Ph.D.
Assistant Professor
Psychology
Associate Director
Cofrin Logan Center for Addiction Research and Treatment
The University of Kansas
Pioneers in Biomedical Research Seminar: U.S. Tobacco Companies Flooded the U.S. Food Supply with Hyper-palatable Foods: Implications for Our Food Environment and Public Health
Date: Feb. 16, 2024
Time: 11 a.m. - 12 p.m.
Archived video
About this Seminar
Between the 1980’s and early 2000’s, U.S. tobacco companies owned and developed leading U.S. food companies. Dr. Fazzino will present scientific evidence indicating that U.S. tobacco companies Phillip Morris and RJ Reynolds may have preferentially disseminated hyper-palatable foods into the U.S. food system. The U.S. food environment is saturated with hyper-palatable foods, and findings indicate that tobacco company involvement in the food system may have had substantial consequences for our current food environment. Policy regulation should be considered to address hyper-palatable food availability and protect public health.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Center for Health Behaviors Research and the Addiction Recovery Research Center. The Pioneers in Biomedical Research Seminar Series, which runs annually from September to May, has featured leading biomedical researchers from throughout the country since the program began in 2012. The lectures are also open to all members of the Virginia Tech community including graduate students, undergraduates, faculty, and staff, as well as the public.
You May Also Be Interested In...
-
Home ItemBiobehavioral Susceptibility for Obesity: Behavioral, Genetic and Neuroimaging Studies of Appetite , home
Sept. 6, 2024, 11:00 a.m. | Susan Carnell, Ph.D., Associate Professor, Division of Child and Adolescent Psychiatry, Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine | Co-Sponsored by the Center for Health Behaviors Research and the Addiction Recovery Research Center, Fralin Biomedical Research Institute
-
Home ItemDevelopment of Genome Editor Therapies for Angelman Syndrome , home
Sept. 13, 2024, 11:00 a.m. | Mark J. Zylka, Ph.D., W.R. Kenan, Jr. Distinguished Professor, University of North Carolina at Chapel Hill; Director, UNC Neuroscience Center | Co-Sponsored by the Center for Neurobiology Research, Fralin Biomedical Research Institute
-
Home ItemUnderstanding the Limits of Exercise Responsiveness in Older Adults , home
Sept. 20, 2024, 11:00 a.m. | Ian R. Lanza, Ph.D., Professor of Medicine, Mayo Clinic College of Medicine and Science | Co-Sponsored by the Center for Exercise Medicine Research, Fralin Biomedical Research Institute
-
Home ItemFrom Variant Functionality to Resistance in Cancer , home
Sept. 27, 2024, 11:00 a.m. | Tiki Hayes, Ph.D., Assistant Professor, Department of Molecular and Medical Pharmacology, UCLA David Geffen School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Center – D.C.
-
Home ItemDisrupting Health Care Using Deep Data and Remote Monitoring , home
Oct. 4, 2024, 11:00 a.m. | Michael Snyder, Ph.D., Professor, Genetics, Director, Center for Genomics and Personalized Medicine, Stanford Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Center for Exercise Medicine Research
-
Home ItemMechanisms of Longevity: From Mice to Whales , home
Oct. 10, 2024, 5:30 p.m. (Reception at 5 p.m.) | Vera Gorbunova, Ph.D., Doris Johns Cherry Professor of Biology, Co-director, Rochester Aging Research Center, University of Rochester | Maury Strauss Distinguished Public Lecture